Japan Lifeline Co., Ltd. ("the Company") announced today that at the board of directors meeting held on August 28, the Company has decided to make the following changes to its organizations and personnel.
Changes in the organization structure (Effective since October 1, 2020)
Establish CRM Education Division as a new organization under CRM Department
Transfer Business Strategy Development Office to Regulatory Affairs Headquarters
Changes in personnel (Effective since October 1, 2020)
Employee
New position and title
Name
Old position and title
General Manager of CRM Education
Senior Manager of CRM Marketing
Division of CRM Department of
Yoshihiko Nasu
Division of CRM Department of
Arrhythmia Business Unit
Arrhythmia Business Unit
Attachments
Original document
Permalink
Disclaimer
JLL - Japan Lifeline Co. Ltd. published this content on 28 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 August 2020 06:12:06 UTC
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.
JAPAN LIFELINE CO., LTD. 
